Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F WIELAND

Showing results (51-60 of 269) with videos related to

Pageof 27
Sort By:
Chemical Science|January 21, 2022
Catalytic asymmetric hydrometallation of cyclobutenes with salicylaldehydesF Wieland Goetzke, Mireia Sidera, Stephen P Fletcher
The Biochemical Journal|May 15, 1995
Plasmodium falciparum-infected erythrocytes utilize a synthetic truncated ceramide precursor for synthesis and secretion of truncated sphingomyelinI Ansorge, D Jeckel, F Wieland, et al.
Organic Letters|March 29, 2020
An Asymmetric Suzuki-Miyaura Approach to Prostaglandins: Synthesis of TafluprostRoman Kučera, F Wieland Goetzke, Stephen P Fletcher
Chemical Science|February 25, 2022
Correction: Catalytic asymmetric hydrometallation of cyclobutenes with salicylaldehydesF Wieland Goetzke, Mireia Sidera, Stephen P Fletcher
MMW, Munchener Medizinische Wochenschrift|March 4, 1983
[Current status of therapy for kidney carcinoma]E Schmiedt, W F Wieland, F J Marx
Angewandte Chemie (International Ed. in English)|June 28, 2019
Enantio- and Diastereoselective Suzuki-Miyaura Coupling with Racemic BicyclesF Wieland Goetzke, Mike Mortimore, Stephen P Fletcher
Hepatology (Baltimore, Md.)|October 24, 2006
The half-life of hepatitis B virionsJohn M Murray, Robert H Purcell, Stefan F Wieland
Medical Care|March 1, 1971
Predicting attrition during the outpatient detoxification of narcotic addictsW R Cuskey, C D Chambers, W F Wieland
Urology|February 20, 2004
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experienceAndreas Blana, Bernhard Walter, Sebastian Rogenhofer, et al.
World Journal of Urology|October 26, 2012
First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survivalWolfgang Otto, Stefan Denzinger, Wolf F Wieland, et al.
Pageof 27

Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
Chemical Science|January 21, 2022
Catalytic asymmetric hydrometallation of cyclobutenes with salicylaldehydesF Wieland Goetzke, Mireia Sidera, Stephen P Fletcher
The Biochemical Journal|May 15, 1995
Plasmodium falciparum-infected erythrocytes utilize a synthetic truncated ceramide precursor for synthesis and secretion of truncated sphingomyelinI Ansorge, D Jeckel, F Wieland, et al.
Organic Letters|March 29, 2020
An Asymmetric Suzuki-Miyaura Approach to Prostaglandins: Synthesis of TafluprostRoman Kučera, F Wieland Goetzke, Stephen P Fletcher
Chemical Science|February 25, 2022
Correction: Catalytic asymmetric hydrometallation of cyclobutenes with salicylaldehydesF Wieland Goetzke, Mireia Sidera, Stephen P Fletcher
MMW, Munchener Medizinische Wochenschrift|March 4, 1983
[Current status of therapy for kidney carcinoma]E Schmiedt, W F Wieland, F J Marx
Angewandte Chemie (International Ed. in English)|June 28, 2019
Enantio- and Diastereoselective Suzuki-Miyaura Coupling with Racemic BicyclesF Wieland Goetzke, Mike Mortimore, Stephen P Fletcher
Hepatology (Baltimore, Md.)|October 24, 2006
The half-life of hepatitis B virionsJohn M Murray, Robert H Purcell, Stefan F Wieland
Medical Care|March 1, 1971
Predicting attrition during the outpatient detoxification of narcotic addictsW R Cuskey, C D Chambers, W F Wieland
Urology|February 20, 2004
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experienceAndreas Blana, Bernhard Walter, Sebastian Rogenhofer, et al.
World Journal of Urology|October 26, 2012
First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survivalWolfgang Otto, Stefan Denzinger, Wolf F Wieland, et al.
Pageof 27